Before you sign or pay
- Court record: 3 federal cases name Outlook Therapeutics, Inc. under its legal name in its state, 2 still open on the docket; the latest is Lewis v. Outlook Therapeutics, Inc., filed 2024-10-10.
- Bankruptcy: no bankruptcy or receivership report found under Outlook Therapeutics, Inc. in our SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Kevin Lundquist, Chief Financial Officer (Form 8-K filed 2026-08-27). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Empery Asset Management, LP (filed 2026-10-13).
Who is behind it
Outlook Therapeutics, Inc.: incorporated in Delaware; business address in Iselin, New Jersey; industry Biological Products, (No Diagnostic Substances) (Schedule 13G, 2026-10-13).
Officers and directors, each with the role and the filing that names them:
- Randy H. Thurman: Director (Form D, 2026-05-07)
- Yezan Haddadin: Director (Form D, 2026-05-07)
- Kurt J. Hilzinger: Director (Form D, 2026-05-07)
- Lawrence A. Kenyon: Executive Officer, Director (Form D, 2026-05-07)
- Faisal G. Sukhtian: Director (Form D, 2026-05-07)
- Andong Huang: Director (Form D, 2026-05-07)
- Gerd Auffarth: Director (Form D, 2026-05-07)
- Julian Gangolli: Director (Form D, 2026-05-07)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-10-13 | Empery Asset Management, LP | 8.73% |
| Schedule 13G, 2026-08-19 | Cvi Investments, Inc. | 9.9% |
| Schedule 13D/A, 2026-08-14 | Gms Ventures & Investments | 16.4% |
| Schedule 13D/A, 2026-06-01 | Gms Ventures & Investments | 22.9% |
| Schedule 13G, 2026-04-24 | Mitchell P. Kopin | 4.99% |
| Schedule 13G/A, 2026-02-05 | Sphera Funds Management LTD. | 4.69% |
| Schedule 13G/A, 2025-10-21 | Empery Asset Management, LP | 4.99% |
| Schedule 13G/A, 2025-08-14 | Great Point Partners, LLC | 4.99% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-27 | Kevin Lundquist | Chief Financial Officer | appointed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-05-07 | $0 | $5M |
| Form D, 2025-01-27 | $0 | $31.98M |
| Form D, 2024-04-16 | $5M | $13.25M |
| Form D, 2024-03-29 | $60M | $159M |
| Form D, 2023-01-06 | $1.03M | $1.03M |
| Form D, 2023-01-06 | $31.82M | $31.82M |
Court and legal record
| Case | Court | Filed | Status |
|---|---|---|---|
| Lewis v. Outlook Therapeutics, Inc. | District Court, D. Delaware | 2024-10-10 | open |
| MANIATTY v. OUTLOOK THERAPEUTICS, INC. | District Court, D. New Jersey | 2023-12-22 | closed 2024-02-09 |
| ALSAIDI v. OUTLOOK THERAPEUTICS, INC. | District Court, D. New Jersey | 2023-11-03 | open |
A docket records that a case was brought, not that anything in it is true.
Red flags found
2 open federal cases (latest Lewis v. Outlook Therapeutics, Inc.).
Related pages
Funding and filing historyLeadership changes5%+ holdersCourt record
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/outlook-therapeutics-incLast updated 2026-10-18
Primary record: Schedule 13G, 2026-10-13 · Form D, 2026-05-07 · Docket, Lewis v. Outlook Therapeutics, Inc. · Docket, MANIATTY v. OUTLOOK THERAPEUTICS, INC.
Who owns Outlook Therapeutics, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/outlook-therapeutics-inc